You are currently viewing a new version of our website. To view the old version click .

SARS-CoV-2 Research in Belgium

This special issue belongs to the section “SARS-CoV-2 and COVID-19“.

Special Issue Information

Dear Colleagues,

Following the initial detection of the first COVID-19 infection in Belgium on February 3, 2020, many Belgian research groups initiated a wide panel of research initiatives targeting different aspects of the SARS-CoV-2 pandemic. In this Special Issue, we aim to collect and synergise this wide variety of high-quality research efforts on SARS-CoV-2 in Belgium. Because the pandemic and its consequences on the health system and society in general outpaces the traditional scope of virology research, we aim to stimulate outstanding virology research, but also research papers which have taken a multidisciplinary approach to complex problems. Manuscripts covering the analysis of the different waves of the pandemic that hit Belgium and localised outbreaks in nursing homes, hospitals, the work sector and schools will be analysed with a great deal of attention, together with studies on phylogenetic and phylodynamic inference, outbreak and transmission chain analysis, clinical studies assessing the impact of novel diagnostic or treatment approaches, next-generation sequencing efforts, mathematical and epidemiological model development, vaccine efficacy, and intervention strategies.

Dr. Guy Baele
Dr. Emmanuel André
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • SARS-CoV-2
  • COVID-19
  • Outbreak analysis
  • Transmission chain analysis
  • Pathogen phylodynamics
  • Next-generation sequencing
  • Vaccine efficacy
  • Demographic analysis
  • Epidemiological models
  • Diagnostics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Viruses - ISSN 1999-4915